Rocket One (RKTO) Cash from Operations (2018 - 2026)
Rocket One's (RKTO) quarterly Cash from Operations came in at -$3.0 million in Q2 2026, down 25.12% year-over-year from -$4.0 million in Q2 2025, and up 2.68% quarter-over-quarter from -$3.1 million in Q1 2026.
Analysis
Rocket One (RKTO) Cash from Operations (2018 - 2026) Analysis & Trends
Rocket One has disclosed Cash from Operations across 9 years of filings, most recently posting -$3.0 million for Q2 2026.
- In Q2 2026, Cash from Operations fell 25.12% year-over-year to -$3.0 million; the TTM figure through Jun 2026 stood at -$10.7 million (down 20.84% YoY), while the FY2025 annual figure was -$9.8 million, down 40.49% from the prior year.
- Cash from Operations came in at -$3.0 million for Q2 2026 at Rocket One, up from -$3.1 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of -$1.4 million in Q2 2023 to a low of -$3.1 million in Q4 2023.
- Average Cash from Operations over 5 years is -$2.3 million, with a median of -$2.3 million recorded in 2022.
- Year-over-year, Cash from Operations surged 34.78% in 2023 and plunged 61.72% in 2025.
- Over 5 years, Cash from Operations stood at -$2.6 million in 2022, then retreated by 20.44% to -$3.1 million in 2023, then surged by 33.97% to -$2.0 million in 2024, then dropped by 6.03% to -$2.2 million in 2025, then tumbled by 38.06% to -$3.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$3.0 million in Q2 2026, -$3.1 million in Q1 2026, and -$2.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.00 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 3.57 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 1.13 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 813.00 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -526.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 448.90 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -270.50 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | -2.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.97 Mn |
| Mar 31, 2026 | -3.05 Mn |
| Dec 31, 2025 | -2.15 Mn |
| Sep 30, 2025 | -2.49 Mn |
| Jun 30, 2025 | -2.37 Mn |
| Mar 31, 2025 | -2.79 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -1.59 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -3.07 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -2.29 Mn |
| Dec 31, 2022 | -2.55 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | -2.22 Mn |
| Mar 31, 2022 | -2.14 Mn |
| Dec 31, 2021 | -3.90 Mn |
| Sep 30, 2021 | -2.70 Mn |